èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Applied Therapeutics, Inc. ã¯ãå¿è¡ç®¡çŸæ£ãã¬ã©ã¯ããŒã¹è¡çãç³å°¿ç
å䜵çãæšçãšããæ°è£œåãéçºããŠããŸããäž»å補ååè£ã¯ AT-007 ã§ãå¥åº·ãªãã©ã³ãã£ã¢ããã³æäººã®ã¬ã©ã¯ããŒã¹è¡çã®æ²»çè¬ãšããŠç¬¬ I/II çžè©Šéšãå®äºããŠãããå°å
ã®ã¬ã©ã¯ããŒã¹è¡çã®æ²»çè¬ããœã«ãããŒã«è±æ°ŽçŽ é
µçŽ æ¬ æçã®æ²»çè¬ãããã³ãã¹ããã³ãã ã¿ãŒãŒé
µçŽ CDG ã®æ²»çè¬ãšããŠå°å
èšåºè©Šéšãè¡ãããŠããŸããå瀟ã¯ãŸããç³å°¿ç
æ§å¿ççã®æ²»çè¬ãããã³ç³å°¿ç
æ§æ«æ¢¢ç¥çµéå®³ã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšäžã® AT-001 ãéçºããŠããŸããåèšåºæ®µéã®è£œåã«ã¯ãç³å°¿ç
æ§ç¶²èçã®æ²»çè¬ AT-003 ããããŸãã AT-104 ã¯ãåžå°è¡æ¶²è
«çåŠ T çŽ°èæ¥æ§ãªã³ãæ§çœè¡ç
ã®æ²»çãç®çãšãã PI3K é»å®³å€ã§ããApplied Therapeutics, Inc. 㯠2016 幎ã«èšç«ããããã¥ãŒãšãŒã¯å·ãã¥ãŒãšãŒã¯ã«æ¬ç€Ÿã眮ããŠããŸãã